Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

US Pharmaceuticals Ishares ETF (IHE)

US Pharmaceuticals Ishares ETF (IHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Pharma ETFs Gain Post Q1 Earnings Zacks - Tue May 9, 2023

Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the past month.

JNJ : 146.75 (+0.42%)
PJP : 77.63 (+1.61%)
IHE : 63.64 (+0.52%)
XPH : 39.96 (+1.10%)
PPH : 86.99 (+0.22%)
FTXH : 26.10 (+0.72%)
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? Zacks - Mon Apr 24, 2023

Sector ETF report for PPH

PPH : 86.99 (+0.22%)
AZN : 75.47 (+0.40%)
MRK : 129.90 (-0.99%)
MCK : 537.12 (-1.14%)
PJP : 77.63 (+1.61%)
IHE : 63.64 (+0.52%)
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)? Zacks - Fri Apr 21, 2023

Sector ETF report for XPH

XPH : 39.96 (+1.10%)
MRK : 129.90 (-0.99%)
AXSM : 73.86 (+3.00%)
IHE : 63.64 (+0.52%)
PPH : 86.99 (+0.22%)
HRMY : 29.26 (-0.20%)
ETFs to Buy on Solid Q1 JNJ Earnings Results Zacks - Wed Apr 19, 2023

Johnson & Johnson (JNJ) continued with its long streak of earnings beat. It topped the revenue estimate as well as lifted the full-year outlook.

JNJ : 146.75 (+0.42%)
XLV : 140.27 (+0.22%)
IYH : 58.76 (+0.26%)
VHT : 256.09 (+0.30%)
IHE : 63.64 (+0.52%)
PPH : 86.99 (+0.22%)
Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now? Zacks - Mon Apr 10, 2023

Smart Beta ETF report for PJP

PJP : 77.63 (+1.61%)
PFE : 25.58 (+0.71%)
MRK : 129.90 (-0.99%)
ABBV : 161.15 (+0.96%)
IHE : 63.64 (+0.52%)
PPH : 86.99 (+0.22%)
Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)? Zacks - Mon Mar 20, 2023

Sector ETF report for PJP

PJP : 77.63 (+1.61%)
PFE : 25.58 (+0.71%)
MRK : 129.90 (-0.99%)
ABBV : 161.15 (+0.96%)
IHE : 63.64 (+0.52%)
PPH : 86.99 (+0.22%)
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Zacks - Mon Mar 20, 2023

Sector ETF report for IHE

IHE : 63.64 (+0.52%)
JNJ : 146.75 (+0.42%)
LLY : 735.86 (+0.32%)
PJP : 77.63 (+1.61%)
PPH : 86.99 (+0.22%)
VTRS : 11.77 (+1.73%)
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? Zacks - Wed Mar 15, 2023

Smart Beta ETF report for XPH

XPH : 39.96 (+1.10%)
MRK : 129.90 (-0.99%)
AXSM : 73.86 (+3.00%)
IHE : 63.64 (+0.52%)
PPH : 86.99 (+0.22%)
HRMY : 29.26 (-0.20%)
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? Zacks - Tue Feb 21, 2023

Sector ETF report for PPH

PPH : 86.99 (+0.22%)
AZN : 75.47 (+0.40%)
MRK : 129.90 (-0.99%)
MCK : 537.12 (-1.14%)
PJP : 77.63 (+1.61%)
IHE : 63.64 (+0.52%)
A Look at Pharma ETFs Post Q4 Earnings Zacks - Wed Feb 8, 2023

Combining the actual results with the estimates for the still-to-report companies, total earnings for the healthcare sector are expected to decline 9% on revenue growth of 4.3%.

BMY : 44.67 (-0.40%)
JNJ : 146.75 (+0.42%)
PFE : 25.58 (+0.71%)
MRK : 129.90 (-0.99%)
LLY : 735.86 (+0.32%)
PJP : 77.63 (+1.61%)
IHE : 63.64 (+0.52%)
XPH : 39.96 (+1.10%)
PPH : 86.99 (+0.22%)
FTXH : 26.10 (+0.72%)

Barchart Exclusives

GE Healthcare vs. GE Aerospace: Which Blue-Chip Spinoff Stock Is a Better Buy? Barchart - 43 minutes ago
General Electric spinoff stocks GE HealthCare and GE Aerospace have outperformed the broader market in 2024, and bullish analysts predict up to 25% upside potential for both. But which of these two blue-chip stocks is a better buy? Let's find out. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot